Connecting patients to clinical trials and care
For cancer patients, access to the right clinical trial can mean the difference between hopeful options and frustrating dead ends.
Yet patients face a complicated and fragmented landscape. Trials are scattered across institutions. Information is incomplete.
Navigating this space is nearly impossible without expert guidance.
Many patients who could benefit from cutting-edge research never find it. The trials exist. As do the patients. It’s a reliable connection that’s missing.
This is an access gap. And it costs lives.
We seek to connect sarcoma patients directly to clinical trials, research, and care options they could not access on their own.
Sarcoma is a rare cancer affecting approximately 16,000 Americans each year. Its rarity means there are fewer treatment options, less research funding, and greater navigation challenges for patients. When you’re facing a rare cancer, finding the right trial shouldn’t require luck or connections.
Fight Sarcoma seeks to build bridges between patients and the trials that could change their prognosis.
We are building a system that identifies relevant trials, matches patients to opportunities, and guides them through the complexities of enrollment.
We created a system that identifies relevant trials, matches patients to opportunities, and guides them through the enrollment process.
Patients accessing trials that were previously unknown or out of reach is our only objective.
Through Fight Sarcoma, we seek to connected thousands of sarcoma patients with clinical trials, care options, and support services they could not access on their own.
Patients who faced dead ends found pathways. Families who felt lost found guidance. People who had no options discovered trials that offered hope.
This is what closing access gaps looks like.
